Investment

US Stocks

Invest in the world’s largest market with US Stocks

Crypto

Unleash the unlimited potential of Crypto

Mutual Funds

Worry-free investments with Mutual Funds

Gold

The simplest way to invest in Gold

Explore

Choose from 900+ available assets

Features

Pro Tools for Pro Traders

Uncover the powerful trading features

Pro Features

Pluang Web Trading

Leverage

Built for Investors

Experience investing with simplified features

Pockets

Recurring Buy

USD Yield

Pluang Cuan

Fees

Safety

Academy

Latest for You

Get up-to-date financial news and investing tips & information

Blog

Find various tips & information to become a knowledgeable investor

News and Analysis

Read the latest information about finance and investment

Learn

Become a smarter investor by learning the basics of investing

Glossary

Learn investment terms to understand investing better

More

Promo & Referral

Discover exclusive opportunities to level up your investments

Investment Clubs (Coming Soon)

Join hands with like-minded investors to grow wealth together

Press (Coming Soon)

Stay updated with our latest news and media coverage

Support

About Us

Contact

Ask

Career

Tax Reporting Guide

Pluang+

|

Novavax Inc (NVAX) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Technical Indicators

|

|

|

Overall Summary

Bearish (15)

Neutral (6)

Bullish (6)

Performance

NVAX ROI

+62.91%

% from 52W High

-40.1%

$12.56

52W Low: $3.76

05 Feb 2024

52W High: $20.97

05 Jun 2024

News

Zacks Investment

2mo

Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy? - Zacks Investment Research

Benzinga

2mo

What the Options Market Tells Us About Novavax - Benzinga

The Motley Fool

3mo

Where Will Novavax Be in 1 Year?

Zacks Investment

3mo

Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks Investment

3mo

Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item

item

item